Sameer Lapsia
Pediatric Gastroenterology · Norfolk, VANPI 1750549606
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Sanofi at 42.8% of the total. Reporting peaked in 2024 at $2,899 and has fallen 71.2% since, to $836 in 2025. Among pediatric gastroenterology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $67.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- AbbVie$706
- QOL Medical, LLC$654
- Takeda Pharmaceuticals U.S.A., Inc.$508
- Johnson & Johnson$255
- Shire North American Group Inc$242
- plus $1K from 17 others
Across 13 payments — averaging $5258.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$68K
- AbbVie$227
What the payments were for
- Consulting fees$2,25937%
- Speaking & faculty fees$82313%
- Food & beverage$3,01649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 6 | $2,610 |
| AbbVie | 11 | $706 |
| QOL Medical, LLC | 25 | $654 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $508 |
| Johnson & Johnson | 9 | $255 |
| Shire North American Group Inc | 3 | $242 |
| Mirum Pharmaceuticals, Inc. | 3 | $203 |
| Regeneron Healthcare Solutions, Inc. | 7 | $154 |
| Medtronic | 4 | $130 |
| Albireo Pharma, Inc. | 1 | $121 |
| Pfizer | 1 | $120 |
| Neurelis, Inc. | 1 | $93 |
| Phadia US Inc. | 1 | $78 |
| Boston Scientific | 1 | $50 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $21 |
| Alcresta Therapeutics, Inc. | 1 | $19 |
| Coloplast | 1 | $19 |
| Dentsply IH AB | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,098 in reported general payments places this provider in the 90th percentile of 43 pediatric gastroenterology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 14 | $159 |
Paid to pharmacies, not to this prescriber.
Other pediatric gastroenterology in Norfolk
- Nancy YokoisNorfolk$3K
- Victor TsouNorfolk$2K
- Rana AmmouryNorfolk$2K
- Michael KonikoffNorfolk$2K
- Orhan AtayNorfolk$833
- Barrett BarnesCharlottesville$30K
- Frank DipaolaCharlottesville$16K
- Juan VillalonaRichmond$7K
- Sean MooreCharlottesville$5K
- Mariana MiddelhofFairfax$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.